TY - JOUR
T1 - Metastatic thyroid cancer occurring as an unknown primary lesion
T2 - The role of F-18 FDG positron emission tomography
AU - Dede, Faut
AU - Yulisa Ajoedi, Nyimas Diana
AU - Ansari, Selim M.
AU - Jana, Suman
AU - Heiba, Sherif I.
AU - Abdel-Dayem, Hussein M.
PY - 2001
Y1 - 2001
N2 - Thyroid cancer can appear as metastatic disease of an unknown primary origin, and fluorine-18 fluorodeoxyglucose (F-18 FDG) positron emission tomographic (PET) studies are helpful in the workup evaluation of these patients. The authors describe two patients who had metastatic disease from an unknown primary lesion. F-18 FDG PET studies played an important role in localizing the primary malignant site in the thyroid gland. The utility of F-18 FDG imaging in decreasing the number of procedures, cost, and inconvenience to patients is shown clearly in both cases.
AB - Thyroid cancer can appear as metastatic disease of an unknown primary origin, and fluorine-18 fluorodeoxyglucose (F-18 FDG) positron emission tomographic (PET) studies are helpful in the workup evaluation of these patients. The authors describe two patients who had metastatic disease from an unknown primary lesion. F-18 FDG PET studies played an important role in localizing the primary malignant site in the thyroid gland. The utility of F-18 FDG imaging in decreasing the number of procedures, cost, and inconvenience to patients is shown clearly in both cases.
KW - F-18 Fluorodeoxyglucose Positron Emission Tomography
KW - Metastatic Thyroid Cancer
KW - Unknown Primary
UR - https://www.scopus.com/pages/publications/0035034347
U2 - 10.1097/00003072-200105000-00004
DO - 10.1097/00003072-200105000-00004
M3 - Article
C2 - 11317017
AN - SCOPUS:0035034347
SN - 0363-9762
VL - 26
SP - 396
EP - 399
JO - Clinical Nuclear Medicine
JF - Clinical Nuclear Medicine
IS - 5
ER -